Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/42709
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFaria, Claudia Dutra Costantin
dc.contributor.authorRibeiro, Simone
dc.contributor.authorKochi, Cristiane
dc.contributor.authorSilva, Aryane Pereira Neves da
dc.contributor.authorRibeiro, Bruna Natalia Freire
dc.contributor.authorMarçal, Lilian Teixeira
dc.contributor.authorSantos, Felipe Henrique Yyazawa
dc.contributor.authorCalliari, Luis Eduardo Procopio [UNIFESP]
dc.contributor.authorMonte, Osmar
dc.contributor.authorLongui, Carlos Alberto
dc.date.accessioned2018-06-15T14:00:11Z-
dc.date.available2018-06-15T14:00:11Z-
dc.date.issued2011-11-01
dc.identifierhttp://dx.doi.org/10.1590/S0004-27302011000800018
dc.identifier.citationArquivos Brasileiros De Endocrinologia E Metabologia. Rio De Janeiro, Rj: Sbem-soc Brasil Endocrinologia & Metabologia, v. 55, n. 8, p. 628-631, 2011.
dc.identifier.issn0004-2730
dc.identifier.urihttp://repositorio.unifesp.br/11600/42709-
dc.description.abstractIntroduction: Patients with Down syndrome (DS) often have elevated TSH (hypothalamic origin), which is called TSH neurosecretory dysfunction (TSH-nd). In these cases, there is slight elevation in TSH (5-15 mu UI/mL), with normal free T4 and negative thyroid antibodies (AB). Objective: To recognize the risk of progression to Hashimoto's thyroiditis (HT). Subjects and methods: We retrospectively analyzed 40 DS patients (mean age = 4.5 years), followed up for 6.8 years. Results: HT was diagnosed in 9/40 patients, three early in monitoring, and six during evolution. In 31/40 patients, TSH-nd diagnosis remained unchanged over the years, with maximum TSH values ranging from 5 to 15 mu UI/mL. In this group, free T4 also remained normal and AB were negative. There was a significant TSH reduction (p = 0.017), and normal TSH concentrations (< 5.0 mu UI/mL) were observed in 29/31 patients, in at least one moment. No patient had TSH > 15 mu UI/mL. Conclusion: DS patients with TSH-nd present low risk of progression to HT (10% for females and 6% for males). Arq Bras Endocrinol Metab. 2011;55(8):628-31en
dc.format.extent628-631
dc.language.isoeng
dc.publisherSbem-soc Brasil Endocrinologia & Metabologia
dc.relation.ispartofArquivos Brasileiros De Endocrinologia E Metabologia
dc.rightsAcesso aberto
dc.subjectDown syndromeen
dc.subjectHashimoto's thyroiditisen
dc.subjectTSH neurosecretory dysfunctionen
dc.subjectisolated TSH elevationen
dc.titleTSH neurosecretory dysfunction (TSH-nd) in Down syndrome (DS): low risk of progression to Hashimoto's thyroiditisen
dc.title.alternativeDisfunção neurossecretora de TSH na síndrome de Down: baixo risco de progressão para a tireoidite de Hashimotopt
dc.typeArtigo
dc.contributor.institutionFac Ciencias Med Santa Casa Sao Paulo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationFac Ciencias Med Santa Casa Sao Paulo, Dept Physiol, BR-01221020 Sao Paulo, Brazil
dc.description.affiliationISCMSP, Dept Pediat, Pediat Endocrinol Unit, Sao Paulo, Brazil
dc.identifier.fileS0004-27302011000800018.pdf
dc.identifier.scieloS0004-27302011000800018
dc.identifier.doi10.1590/S0004-27302011000800018
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000298885900018
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.